These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 2091056)
1. Combined external beam and interstitial radiotherapy. Radiobiological and clinical considerations. Biagini C Rays; 1990; 15(4):451-66. PubMed ID: 2091056 [No Abstract] [Full Text] [Related]
2. Radiobiological considerations of brachytherapy. Glicksman AS; Leith JT Oncology (Williston Park); 1988 Jan; 2(1):25-32. PubMed ID: 3079317 [TBL] [Abstract][Full Text] [Related]
3. Limitations in Dose Specification of Brachytherapy Combined With External Beam Irradiation. Wilson JF; Moulder JE Semin Radiat Oncol; 1993 Oct; 3(4):301-308. PubMed ID: 10717082 [TBL] [Abstract][Full Text] [Related]
4. Staging and target volume. Clinical problems in combined curietherapy and external radiotherapy. Volterrani F Rays; 1990; 15(4):476-80. PubMed ID: 2091058 [No Abstract] [Full Text] [Related]
5. Clinical efficacy of brachytherapy combined with external-beam radiotherapy and repeated arterial infusion chemotherapy in patients with unresectable extrahepatic bile duct cancer. Nomura M; Yamakado K; Nomoto Y; Nakatsuka A; Ii N; Shoji K; Takeda K Int J Oncol; 2002 Feb; 20(2):325-31. PubMed ID: 11788896 [TBL] [Abstract][Full Text] [Related]
6. Criteria for comparison of combined external radiotherapy and curietherapy. Sannazzari GL Rays; 1990; 15(4):539-45. PubMed ID: 2091065 [No Abstract] [Full Text] [Related]
7. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587 [TBL] [Abstract][Full Text] [Related]
8. 192Ir low dose rate brachytherapy for boosting locally advanced prostate cancers after external beam radiotherapy: a phase II trial. Nickers P; Coppens L; de Leval J; Jansen N; Deneufbourg JM Radiother Oncol; 2006 Jun; 79(3):329-34. PubMed ID: 16780976 [TBL] [Abstract][Full Text] [Related]
9. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy. Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108 [TBL] [Abstract][Full Text] [Related]
10. Volume correction factor in time dose relationships in brachytherapy. Supe SJ; Sasane JB; Gupta MK Strahlenther Onkol; 1987 May; 163(5):309-13. PubMed ID: 3589957 [TBL] [Abstract][Full Text] [Related]
11. Electronic brachytherapy: comparisons with external-beam and high-dose-rate 192Ir brachytherapy. Holt RW; Rivard MJ J Am Coll Radiol; 2008 Mar; 5(3):221-3. PubMed ID: 18312972 [No Abstract] [Full Text] [Related]
12. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer. Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470 [TBL] [Abstract][Full Text] [Related]
13. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904 [TBL] [Abstract][Full Text] [Related]
14. External beam radiotherapy and high dose rate brachytherapy for medically unfit and elderly patients. Marijnen CA Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):706-10. PubMed ID: 17826039 [TBL] [Abstract][Full Text] [Related]
15. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Selker RG; Shapiro WR; Burger P; Blackwood MS; Arena VC; Gilder JC; Malkin MG; Mealey JJ; Neal JH; Olson J; Robertson JT; Barnett GH; Bloomfield S; Albright R; Hochberg FH; Hiesiger E; Green S; Neurosurgery; 2002 Aug; 51(2):343-55; discussion 355-7. PubMed ID: 12182772 [TBL] [Abstract][Full Text] [Related]
16. Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment. Stromberg JS; Martinez AA; Horwitz EM; Gustafson GS; Gonzalez JA; Spencer WF; Brabbins DS; Dmuchowski CF; Hollander JB; Vicini FA Cancer J Sci Am; 1997; 3(6):346-52. PubMed ID: 9403047 [TBL] [Abstract][Full Text] [Related]
17. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models. King CR Brachytherapy; 2002; 1(4):219-26. PubMed ID: 15062170 [TBL] [Abstract][Full Text] [Related]
18. High dose rate sources in remote afterloading brachytherapy: implications for intracavitary and interstitial treatment of carcinoma. Syzek EJ; Bogardus CR J Okla State Med Assoc; 1990 Nov; 83(11):541-5. PubMed ID: 2273417 [TBL] [Abstract][Full Text] [Related]
19. The role of external beam in brachytherapy. Zaider M; Zelefsky MJ; Cohen GN; Chui CS; Yorke ED; Hunt MA; Happersett L Future Oncol; 2007 Apr; 3(2):159-68. PubMed ID: 17381416 [TBL] [Abstract][Full Text] [Related]
20. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation. Demanes DJ; Brandt D; Schour L; Hill DR Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]